IL6 and COVID-19: Our identification of circulating inflammatory mediators that associate with COVID-19 disease severity such as CRP and IL-6 are consistent with previous reports and support the hypothesis that an overly aggressive immune response contributes to immunopathology and severity.30,31 In addition to severity associated factors, we have identified a subset of eight cytokines that are further dysregulated in severe patients with a fatal outcome.